Clinical Trial Update: A Study to Evaluate Efficacy and Safety of MELT-300 for Procedural Sedation in Subjects Undergoing Cataract Extraction With Lens Replacement (CELR) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating the efficacy and safety of MELT-300 for procedural sedation in cataract extraction with lens replacement (CELR), currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cataract

Drugs mentioned

• MELT-300

Snippet

Sponsor: Melt Pharmaceuticals | Conditions: Cataract | Phase 3 | Status: RECRUITING